Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Cellectis S.A. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 29 | 27 | −2 |
| Shares | 12.8M | 13.6M | +843.0K (+6.6%) |
| Value | $23.0M | $16.9M | −$6.10M (−26.6%) |
New holders (3)
Institutions that held Cellectis S.A. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Old Mission Capital LLC | 25,289 | $31.4K | 0.00% |
| Cubist Systematic Strategies, LLC | 10,859 | $13.5K | 0.00% |
| Federation des caisses Desjardins du Quebec | 10,711 | $13.3K | 0.00% |
Sold out (5)
Institutions that held Cellectis S.A. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Capital International Investors | 1,848,804 | $3.33M |
| Citadel Advisors LLC | 34,786 | $62.6K |
| Two Sigma Investments, LP | 27,322 | $49.2K |
| XTX Topco Ltd | 10,526 | $18.9K |
| Advisor Group Holdings, Inc. | 303 | $546 |